UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL

Cancers, 2023-02, Vol.15 (4), p.1349

2023

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and myeloproliferative neoplasms

Journal of autoimmunity, 2017-12, Vol.85, p.58-63

2017

Link zum Volltext

Verfügbarkeit prüfen

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

BMC cancer, 2020-10, Vol.20 (1), p.956-12, Article 956

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Frontiers in oncology, 2022-01, Vol.11, p.804714-804714

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis

Epilepsia (Copenhagen), 2015-05, Vol.56 (5), p.e49-e52

2015

Link zum Volltext

Verfügbarkeit prüfen

Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera

Journal of hematology and oncology, 2017-02, Vol.10 (1), p.54-54, Article 54

2017

Link zum Volltext

Verfügbarkeit prüfen

Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

Mediterranean journal of hematology and infectious diseases, 2021-09, Vol.13 (1), p.e2021057

2021

Link zum Volltext

Verfügbarkeit prüfen

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL

Blood cancer journal (New York), 2024-04, Vol.14 (1), p.73-73

2024

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of platelet function in essential thrombocythemia under different analytical conditions

Platelets (Edinburgh), 2020-02, Vol.31 (2), p.179-186

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia

Cancers, 2019-09, Vol.11 (10), p.1455

2019

Link zum Volltext

Verfügbarkeit prüfen

Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia

Blood, 2011-09, Vol.118 (12), p.3359-3366

2011

Link zum Volltext

Verfügbarkeit prüfen

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old‐fashioned” Drug be Effective?

HemaSphere, 2023-04, Vol.7 (4), p.e867-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P1180: BURKITT INTERNATIONAL PROGNOSTIC INDEX EVALUATED IN PATIENTS TREATED WITH R‐GMALL PROTOCOL

HemaSphere, 2023-08, Vol.7 (S3), p.e39998b5-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL

Cancers, 2021-04, Vol.13 (9), p.2108

2021

Link zum Volltext

Verfügbarkeit prüfen

Ruxolitinib‐associated infections: A systematic review and meta‐analysis

American journal of hematology, 2018-03, Vol.93 (3), p.339-347

2018

Link zum Volltext

Verfügbarkeit prüfen

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia

Clinical case reports, 2022-01, Vol.10 (1), p.e05212-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

Internal and emergency medicine, 2020-04, Vol.15 (3), p.453-462

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia

Mediterranean journal of hematology and infectious diseases, 2014-01, Vol.6 (1), p.e2014065-e2014065

2014

Link zum Volltext

Verfügbarkeit prüfen

Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies

Leukemia & lymphoma, 2021-05, Vol.62 (6), p.1490-1496

2021

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms of the Z protein protease inhibitor and risk of venous thromboembolism: a meta‐analysis

British journal of haematology, 2008-10, Vol.143 (2), p.284-287

2008

Link zum Volltext

Verfügbarkeit prüfen

Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities

The Journal of clinical investigation, 2020-11, Vol.130 (11), p.6021-6033

2020

Link zum Volltext

Verfügbarkeit prüfen

Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study

Blood, 2022-11, Vol.140 (Supplement 1), p.6925-6926

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Hematology
(41)
Humans
(35)
Female
(24)
Male
(21)
Adult
(17)
Middle Aged
(17)
Aged
(15)
Oncology
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Cardiovascular System & Cardiology
(11)
Peripheral Vascular Disease
(11)
Risk Factors
(10)
Acute Lymphoblastic Leukemia
(9)
Leukemia
(9)
Chemotherapy
(8)
Hematologic And Hematopoietic Diseases
(8)
Hematology, Oncology And Palliative Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL

Inflammation and myeloproliferative neoplasms

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis

Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera

Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda

Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL

Evaluation of platelet function in essential thrombocythemia under different analytical conditions

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia

Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old‐fashioned” Drug be Effective?

P1180: BURKITT INTERNATIONAL PROGNOSTIC INDEX EVALUATED IN PATIENTS TREATED WITH R‐GMALL PROTOCOL

MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL

Ruxolitinib‐associated infections: A systematic review and meta‐analysis

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)

Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies

Polymorphisms of the Z protein protease inhibitor and risk of venous thromboembolism: a meta‐analysis

Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities

Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation

Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study

Suchergebnisse filtern